PortfoliosLab logoPortfoliosLab logo
TNGX vs. RVMDW
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TNGX vs. RVMDW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tango Therapeutics, Inc. (TNGX) and Revolution Medicines Inc. Warrant (RVMDW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TNGX achieves a 142.33% return, which is significantly lower than RVMDW's 566.03% return.


TNGX

1D
-0.14%
1M
-5.46%
YTD
142.33%
6M
124.35%
1Y
562.65%
3Y*
88.81%
5Y*
14.42%
10Y*

RVMDW

1D
6.46%
1M
16.79%
YTD
566.03%
6M
662.67%
1Y
3,194.74%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TNGX vs. RVMDW - Yearly Performance Comparison


2026 (YTD)202520242023
TNGX
Tango Therapeutics, Inc.
142.33%186.73%-68.79%30.26%
RVMDW
Revolution Medicines Inc. Warrant
566.03%422.17%-45.45%-67.00%

Correlation

The correlation between TNGX and RVMDW is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Nov 20, 2023

0.09

Fundamentals

Market Cap

TNGX:

$3.08B

RVMDW:

$1.24B

EPS

TNGX:

-$0.89

RVMDW:

-$7.17

PB Ratio

TNGX:

7.87

RVMDW:

0.83

Total Revenue (TTM)

TNGX:

$56.99M

RVMDW:

$0.00

Gross Profit (TTM)

TNGX:

$55.33M

RVMDW:

-$4.70M

EBITDA (TTM)

TNGX:

-$111.92M

RVMDW:

-$1.34B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TNGX vs. RVMDW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TNGX
TNGX Risk / Return Rank: 9898
Overall Rank
TNGX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
TNGX Sortino Ratio Rank: 9898
Sortino Ratio Rank
TNGX Omega Ratio Rank: 9696
Omega Ratio Rank
TNGX Calmar Ratio Rank: 9999
Calmar Ratio Rank
TNGX Martin Ratio Rank: 9999
Martin Ratio Rank

RVMDW
RVMDW Risk / Return Rank: 9999
Overall Rank
RVMDW Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
RVMDW Sortino Ratio Rank: 9999
Sortino Ratio Rank
RVMDW Omega Ratio Rank: 9898
Omega Ratio Rank
RVMDW Calmar Ratio Rank: 100100
Calmar Ratio Rank
RVMDW Martin Ratio Rank: 100100
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TNGX vs. RVMDW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tango Therapeutics, Inc. (TNGX) and Revolution Medicines Inc. Warrant (RVMDW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TNGXRVMDWDifference

Sharpe ratio

Return per unit of total volatility

6.52

13.27

-6.75

Sortino ratio

Return per unit of downside risk

5.05

6.03

-0.98

Omega ratio

Gain probability vs. loss probability

1.63

1.74

-0.12

Calmar ratio

Return relative to maximum drawdown

19.41

54.33

-34.92

Martin ratio

Return relative to average drawdown

51.43

116.19

-64.76

TNGX vs. RVMDW - Sharpe Ratio Comparison

The current TNGX Sharpe Ratio is 6.52, which is lower than the RVMDW Sharpe Ratio of 13.27. The chart below compares the historical Sharpe Ratios of TNGX and RVMDW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TNGXRVMDWDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

6.52

13.27

-6.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

0.15

0.34

-0.19

Drawdowns

TNGX vs. RVMDW - Drawdown Comparison

The maximum TNGX drawdown since its inception was -93.64%, roughly equal to the maximum RVMDW drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for TNGX and RVMDW.


Loading charts...

Drawdown Indicators


TNGXRVMDWDifference

Max Drawdown

Largest peak-to-trough decline

-93.64%

-96.90%

+3.26%

Max Drawdown (1Y)

Largest decline over 1 year

-29.24%

-59.65%

+30.41%

Max Drawdown (3Y)

Largest decline over 3 years

-91.46%

Max Drawdown (5Y)

Largest decline over 5 years

-93.64%

Current Drawdown

Current decline from peak

-22.69%

-9.28%

-13.41%

Average Drawdown

Average peak-to-trough decline

-48.20%

-67.28%

+19.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.02%

27.84%

-16.82%

Volatility

TNGX vs. RVMDW - Volatility Comparison

The current volatility for Tango Therapeutics, Inc. (TNGX) is 27.67%, while Revolution Medicines Inc. Warrant (RVMDW) has a volatility of 29.38%. This indicates that TNGX experiences smaller price fluctuations and is considered to be less risky than RVMDW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TNGXRVMDWDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.67%

29.38%

-1.71%

Volatility (6M)

Calculated over the trailing 6-month period

64.54%

151.04%

-86.50%

Volatility (1Y)

Calculated over the trailing 1-year period

91.07%

249.45%

-158.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

99.00%

314.25%

-215.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.52%

314.25%

-220.73%

Dividends

TNGX vs. RVMDW - Dividend Comparison

Neither TNGX nor RVMDW has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TNGX vs. RVMDW - Financials Comparison

This section allows you to compare key financial metrics between Tango Therapeutics, Inc. and Revolution Medicines Inc. Warrant. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M2022202320242025202600
(TNGX) Total Revenue
(RVMDW) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TNGX and RVMDW have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RVMDW has higher volatility (29.38%) compared to TNGX (27.67%). In terms of maximum drawdown, TNGX dropped -93.64% vs RVMDW's -96.90%.

RVMDW currently has the higher Sharpe Ratio (13.27 vs 6.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TNGX and RVMDW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer